Selected milestones across a 25-year international career.
Doubled EBITDA in Western Europe following a carve-out while delivering strong double-digit growth and exceptional cash generation.
Partnered closely with PE sponsor during company transformation and continued support as Industry Advisor.
Expanded European footprint through market entries in Nordics, Austria & Spain, strengthening the company's regional platform.
Delivered >10% annual sales growth in Asia Pacific, while more than doubling return on sales through portfolio focus and organisational transformation.
Executed major business restructuring, exiting structurally unprofitable operations, transforming businesses from distributor to direct go-to-market.
Increased operating income by 130% in the Nordics, following consolidation into a regional commercial organisation.
Led multiple bolt-on and transformational M&A transactions, including acquisition of a leading OTC portfolio and a specialty pharma company in Germany.
Integrated a $180M established medicines business in China, including a large sales force and complex market environment.
Established high-performing regional leadership teams built on accountability, trust, respect & empowerment. Developed country leadership teams with emphasis on local talent.
Career Timeline
A career built on delivering results
Zentiva
Mar 2019 – Mar 2025
Head Commercial Western Europe & Member of Executive Committee
Prague, Czech Republic · Pan-European
Responsibilities
Regional P&L responsibility for ~€900M across 20 European countries. Reporting to CEO. Responsible for all country organisations as well as regional Finance, HR, Supply Chain and global Analytics & Commercial Excellence.
Key results
Doubled EBITDA for Zentiva Western Europe since carve-out 2018–2024 while delivering strong double-digit growth and very high cash conversion
Managed sustained growth in Germany, United Kingdom, improved profitability in France, initiated turnaround in Italy and Baltics, market entry into Nordics, Spain, Austria
Developed strong Commercial Analytics and Excellence road map including CRM roll-out
Identified and executed a series of bolt-on acquisitions to strengthen Specialty and Consumer Health business across the region
MS Pharma
Sep 2018 – Feb 2019
Chief Operating Officer (COO)
Amman, Jordan · MENA
Responsibilities
Regional P&L responsibility for ~$350M across the MENA region. Reporting to CEO. Responsible for all country organisations and Injectables BU, Regulatory Affairs and Supply Chain in the centre.
Key results
Developed operating model for the group
Conducted commercial due diligence on European CDMO leading to successful acquisition
Sandoz · a Novartis Division
Sep 2017 – Aug 2018
Sabbatical
Sandoz · a Novartis Division
Oct 2013 – Aug 2017
Region Head Asia Pacific & Member of Executive Committee
Singapore · Pan-Asian
Responsibilities
Full P&L responsibility for ~$900M across 17 subsidiaries. Reporting to CEO. Responsible for Finance, HR, Marketing & Sales, Supply Chain, Regulatory Affairs, Business Development and Quality Management.
Key results
Average 10% annual sales growth per annum and doubling return on sales
Strict resource allocation including restructuring, M&A and divestments
Successful integration of $180M established medicines business
Development of an aggressive growth strategy for the branded generics business in China
Reorganisation and expansion of Novartis' global social business activities
Sandoz · a Novartis Division
Oct 2009 – Sep 2013
Country Head Nordics
Copenhagen, Denmark · Pan-Nordics
Responsibilities
Full P&L responsibility for ~$200M across Denmark, Sweden, Finland, Norway and Iceland. Managerial responsibility for 120 employees, 11 direct reports.
Key results
Grew operating income by 130% and sales by 28% from 2009 to 2013 in a stagnating market following successful turnaround
Implementation of innovative pricing approaches for tenders
Establishment of customer-centric Marketing & Sales organisation
Established Nordic organisation with a winning culture
Sandoz · a Novartis Division
Jul 2007 – Sep 2009
Head of Commercial Operations Management Europe
Holzkirchen, Germany · Pan-European
Responsibilities
Commercial operations leadership across the European region, bridging strategic planning and operational execution across multiple country organisations within the Sandoz generics business.
ratiopharm
Jan 2004 – Jun 2007
Head of Strategic Planning & M&A
Ulm, Germany · Global
Responsibilities
Supervision of strategic planning and M&A activities and internal consulting projects at one of Europe's leading generics companies.
Key results
Led strategic planning process across all business units
Managed M&A pipeline and internal consulting projects
Gemini Consulting
Jul 1998 – Dec 2003
Consultant → Managing Consultant
Munich, Germany
Responsibilities
Project management, control, planning and acquisition across strategy consulting engagements. Professional managerial responsibility for up to 20 project employees in joint project teams.
Overview
Progressed from Consultant to Managing Consultant across 5+ years
Led joint project teams of up to 20 professionals across strategy engagements
Focus areas: commercial strategy, operational improvement, M&A support
Scripps Research Institute & University of Bern
Sep 1996 – Jun 1998
Post-doctoral Fellowship
La Jolla, USA & Bern, Switzerland
University of Stuttgart
1992 – 1996
Research Scientist & PhD Student
Stuttgart, Germany
Zentiva
Mar 2019 – Mar 2025
Head Commercial Western Europe & Member of Executive Committee
Prague · Pan-European
Responsibilities
Regional P&L for ~€900M across 20 European countries. Reporting to CEO. Responsible for all country organisations, regional Finance, HR, Supply Chain and global Analytics & Commercial Excellence.
Key results
Doubled EBITDA since carve-out while delivering strong double-digit growth and very high cash conversion
Market entry into Nordics, Spain, Austria; turnaround in Italy and Baltics
Bolt-on acquisitions strengthening Specialty and Consumer Health
MS Pharma
Sep 2018 – Feb 2019
Chief Operating Officer (COO)
Amman, Jordan · MENA
Responsibilities
Regional P&L ~$350M across MENA. Responsible for country organisations, Injectables BU, Regulatory Affairs and Supply Chain.
Key results
Developed operating model for the group
Commercial due diligence on European CDMO leading to successful acquisition
Sandoz
Sep 2017 – Aug 2018
Sabbatical
Sandoz
Oct 2013 – Aug 2017
Region Head Asia Pacific & Member of Executive Committee
Singapore · Pan-Asian
Responsibilities
Full P&L ~$900M across 17 subsidiaries. Reporting to CEO. Finance, HR, Marketing & Sales, Supply Chain, Regulatory Affairs, Business Development, Quality.
Key results
>10% annual sales growth and doubling of return on sales
Integration of $180M established medicines business
Growth strategy for branded generics in China
Sandoz
Oct 2009 – Sep 2013
Country Head Nordics
Copenhagen · Pan-Nordics
Responsibilities
Full P&L ~$200M across Denmark, Sweden, Finland, Norway and Iceland. 120 employees, 11 direct reports.
Key results
Operating income +130%, sales +28% following successful turnaround
Customer-centric Marketing & Sales organisation established
Sandoz
Jul 2007 – Sep 2009
Head of Commercial Operations Management Europe
Holzkirchen, Germany · Pan-European
Responsibilities
Commercial operations leadership across the European region, bridging strategic planning and operational execution across multiple country organisations.